The Morgan Huse Lab
Tello-Lafoz, M., Srpan, K., Sanchez, E. E., Hu, J., Remsik, J., Romin, Y., Calò, A., Hoen, D., Bhanot, U., Morris, L., Boire, A., Hsu, K. C., Massagué, J., Huse, M.*, and Er, E. E.* (2021) Cytotoxic Lymphocytes Target Characteristic Biophysical Vulnerabilities in Cancer. Immunity 54, 1037-1054. * corresponding authors
Tamzalit, F., Wang, M. S., Jin, W., Tello-Lafoz, M., Boyko, V., Heddleston, J. M., Black, C. T., Kam, L. C., and Huse, M. (2019). Interfacial Actin Protrusions Mechanically Enhance Killing by Cytotoxic T Cells. Sci. Immunol., eaav5445.
Morgan Huse, PhD
- Immunologist Morgan Huse studies the structure and function of immune cell-cell interactions.
- PhD, The Rockefeller University
- Searle Scholar Award (2008)
Get in Touch
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Morgan Huse discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.